|
Delayed
Nasdaq
13:11:36 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 1.130 USD | 0.00% |
|
+2.73% | -51.29% |
| Market Cap | 4.55M 4.06M 3.79M 3.44M 6.48M 440M 6.53M 45.53M 17.79M 224M 17.06M 16.69M 719M | P/E 2026 * |
-0.52x | P/E 2027 * | -0.79x |
|---|---|---|---|---|---|
| Enterprise Value | 4.55M 4.06M 3.79M 3.44M 6.48M 440M 6.53M 45.53M 17.79M 224M 17.06M 16.69M 719M | EV / Sales 2026 * |
45.5x | EV / Sales 2027 * | 6.06x |
| Free-Float |
72.65% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DRMA | Delayed | |
CBOE
| DRMA | Real-time |
| 1 day | -0.44% | ||
| 1 week | +2.73% | ||
| Current month | +2.73% | ||
| 1 month | -9.60% | ||
| 3 months | -19.86% | ||
| 6 months | -16.30% | ||
| Current year | -51.29% |
| 1 week | 1.06 | 1.16 | |
| 1 month | 1.06 | 1.31 | |
| Current year | 0.95 | 4.66 | |
| 1 year | 0.95 | 5.18 | |
| 3 years | 0.95 | 149.97 | |
| 5 years | 0.95 | 16,679.99 | |
| 10 years | 0.95 | 16,679.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gerry Proehl
CEO | Chief Executive Officer | 67 | 2014-12-07 |
Kyri van Hoose
DFI | Director of Finance/CFO | 48 | 2021-08-31 |
Cliff Mastricola
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gerry Proehl
CHM | Chairman | 67 | 2021-03-31 |
David Hale
BRD | Director/Board Member | 77 | 2014-12-07 |
Wendell Wierenga
BRD | Director/Board Member | 78 | 2016-09-19 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/16/26 | Free | Chief Financial Officer | 306,120 | 10.7966% | ||
| 2/17/26 | Buy | General Counsel | 1,000 | 0.0353% | ||
| 1/2/26 | Free | Director | 2,500 | 0.0940% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +2.73% | -74.78% | -99.21% | 4.55M | ||
| +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | ||
| +0.46% | -0.97% | +23.51% | +79.57% | 58.81B | ||
| +0.17% | +0.35% | +6.85% | +34.55% | 48.45B | ||
| +0.07% | -2.60% | +329.29% | +684.92% | 42.84B | ||
| -0.58% | -3.81% | +28.76% | +29.61% | 42.79B | ||
| +0.33% | -0.48% | +6.61% | +110.77% | 41.25B | ||
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | ||
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | ||
| +0.54% | -1.75% | -8.94% | -11.65% | 24.05B | ||
| Average | +0.22% | -0.23% | +40.49% | +100.17% | 39.43B | |
| Weighted average by Cap. | +0.68% | -0.54% | +56.16% | +128.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100K 89.35K 83.36K 75.72K 143K 9.67M 144K 1M 391K 4.92M 375K 367K 15.82M | 750K 670K 625K 568K 1.07M 72.55M 1.08M 7.51M 2.94M 36.9M 2.82M 2.75M 119M |
| Net income | -11.08M -9.9M -9.24M -8.39M -15.8M -1.07B -15.92M -111M -43.37M -545M -41.61M -40.71M -1.75B | -13.78M -12.32M -11.49M -10.44M -19.66M -1.33B -19.8M -138M -53.94M -678M -51.74M -50.62M -2.18B |
| Net Debt | - | - |
Employees
9
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-07 | US$1.130 | 0.00% | 6,630 |
| 26-10-06 | US$1.130 | +1.80% | 29,585 |
| 26-10-05 | US$1.110 | +0.45% | 14,158 |
| 26-10-02 | US$1.105 | -0.45% | 18,309 |
| 26-10-01 | US$1.110 | +0.91% | 21,049 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.130USD
Average target price
4.000USD
Spread / Average Target
+253.98%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DRMA Stock
Select your edition
All financial news and data tailored to specific country editions

















